The estimated cost of LSS in the US exceeds 2 billion dollars annually, with an estimated 2-year cost of $10,486 per person for non-surgical care, and $88,000 per surgery. [58,59] There is therefore a ...

Introduction Cognitive impairment is a common consequence after stroke. Intermittent theta burst stimulation (iTBS) has emerged as a promising cognitive therapy. However, traditional iTBS typically ...

Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...

Objective To assess effectiveness equivalence between two commonly prescribed 12-week exercise programmes targeting either the quadriceps or the hip muscles in patients with patellofemoral pain (PFP).

Introduction About 30% of depressed patients suffer from a protracted course in which the disorder continues to cause significant burden despite treatment efforts. While originally developed for ...

Detailed price information for Niagen Bioscience Inc (NAGE-Q) from The Globe and Mail including charting and trades.

Phase 3 The final phase in this project, described here, is a fully powered randomized controlled trial comparing the Spinal Stenosis Pedometer and Nutrition Lifestyle Intervention (SSPANLI) to usual ...